Calcium channel blockers: Monotherapy and dual therapy considerations in the treatment of hypertension

American Journal of Cardiovascular Drugs

Volumn 7, Issue SUPPL. 1, 2007, Pages 1-3

  Sica, Domenic A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL PLUS FELODIPINE; FELODIPINE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL PLUS VERAPAMIL; UNCLASSIFIED DRUG; VERAPAMIL;

ANGINA PECTORIS; BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG POTENCY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HIGH SODIUM INTAKE; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; SYSTOLIC HYPERTENSION; ARTICLE; DOSE RESPONSE; HYPERTENSION; LONG TERM CARE; SHORT COURSE THERAPY;

ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DRUG MONITORING; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION;

EID: 34247616838     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200707010-00001     Document Type: Review

References (13)

1. Abernethy D, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999; 341: 1447-57
2. Sica DA. Pharmacotherapy review - calcium channel blockers. J Clin Hypertens (Greenwich) 2006; 8: 53-6
3. Cappuccio FP, Antonios TFT, Markandu ND, et al. Acute natriuretic effect of nifedipine on different sodium intakes in essential hypertension: evidence for distal tubular effect? J Hum Hypertens 1994; 8: 627-30
4. Fiad TM, Cunningham SK, Hayes FJ. McKenna J: Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. J Clin Endocrinol Metab 1997; 82: 457-60
5. Steffen HM. Use of calcium channel antagonists for the treatment of hypertension in the elderly. Drugs Aging 2004; 21: 565-81
6. White WB, Johnson MF, Black HR, et al. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. Am J Hypertens 2001; 14: 1239-47
7. Gradman AH. Treatment of hypertension with felodipine in patients with concomitant diseases. Clin Cardiol 1993; 16: 294-301
8. Chew CY, Hecht HS, Collett JT, et al. Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol 1981; 47: 917-22
9. Agodoa LY, Appel L, Bakris G, et al. for the African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719-28
10. Nathan S, Pepine CJ, Bakris GL. Calcium antagonists: effects on cardio-renal risk in hypertensive patients. Hypertension 2005; 46: 637-42
11. Sica DA. Combination calcium channel blocker therapy in the treatment of hypertension. J Clin Hypertens (Greenwich) 2001; 3: 322-7
12. Burris JF, Weir MR, Oparil S, et al. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy. JAMA 1990; 263: 1507-12
13. Sica DA. Current concepts of pharmacotherapy in hypertension: thiazide-type diuretics: ongoing considerations on mechanism of action. J Clin Hypertens (Greenwich) 2004; 6: 661-4